Jump To Top

groundrushairsports

Health News

In these difficult times, a simple QnA to provide practical solutions to your problems Part I In the last few months, I have had people book a different kind of session — a QnA hour, in which the...

In years gone past, before the dawn of the modern man, survival was based purely on primal nature. In the modern world, thanks to evolution, civilization and the intricacies of technology, we don’t...

Why experts say there’s no need to panic about Covid variants… at least for now Some fear mutated versions of virus could escape protection given by vaccines It comes after 132 cases of a...

Nobody likes to start off the day already exhausted because they spent the night tossing and turning thanks to insomnia. So if you happen to have some extra NyQuil in the house left over from your last...

In a recent YouTube video, former Olympic medalist Tony Jeffries (who retired undefeated from boxing in 2012) shares his advice on the techniques and mentality that first-time boxers can adopt when they...

Management and outcomes of adults with atrial fibrillation are presented today at EHRA 2021, an online scientific congress of the European Society of Cardiology (ESC). The document is published in EP...

KHN freelancer Christine Spolar discussed how during the pandemic the nation’s richest hospitals and health systems profited after accepting the lion’s share of the federal health care bailout...

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) will add a warning to the Johnson and Johnson...

The first National Institutes of Health (NIH) National Cancer Institute (NCI)-funded clinical study examining stereotactic body radiotherapy (SBRT) in the treatment of oligometastatic breast, prostate,...

Bimekizumab bested adalimumab for moderate to severe plaque psoriasis in a phase 3 trial of adults from the agent’s maker UCB Pharma. The interleukin-17A (IL-17A) and IL-17F blocker has also racked...